|
VRAX Virax Biolabs Group Ltd 1885827 |
| Income Statement |
|
Net Income
|
2025-03-31
|
$-6,067,232.00 |
| Balance Sheet |
|
Current Assets
|
$4,893,655.00 |
|
Assets
|
$6,426,903.00 |
|
Current Liabilities
|
$673,207.00 |
|
Liabilities
|
$964,750.00 |
|
Equity
|
$5,462,153.00 |
|
Shares Out
|
4341956.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-4,563,576.00 |
|
Investing Cash Flow
|
$-603,890.00 |
| Market Analysis |
Market Cap
|
$12,157,476.80 |
|
Price
|
$2.64 |
|
BVPS
|
1.26 |
|
PB
|
2.22 |
|
EPS
|
-1.25 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:47 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:48 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VRAX documents filed with the SEC.
VRAX Filings
Clear
